Wasayansi Wamkulu
Wenqiang Yu, Ph.D.
●Wasayansi Wamkulu wa Pulogalamu ya National "973";
●Pulofesa wosankhidwa mwapadera wa Chang Jiang Scholars Program;
●PI, Center for Epigenetics, Institute of Biomedical Sciences Fudan University;
●Wofufuza Wapadera ndi Woyang'anira Dokotala wa Fudan University;
●Mtsogoleri wa Methylation Marker Expert Committee of the Tumor Marker Committee ya Chinese Anti-Cancer Association.
Mu 1989, adamaliza maphunziro ake ku yunivesite yachinayi ya usilikali ndipo adalandira Bachelor's Degree in Medicine;
Mu 2001, adalandira Degree yake ya Doctorate kuchokera ku Fourth Military Medical University;
Kuchokera ku 2001-2004, adalandira Postdoctoral in Department of Development and Genetics, Uppsala University, Sweden;
Kuchokera ku 2004-2007, adalandira Postdoctoral ku Hopkins University School of Medicine, United States;
Pakadali pano, Pulofesa Yu ndi PI komanso mnzake wofufuza za Institutes of Biomedical Sciences of Fudan University, komanso Executive Deputy Director wa Institute of Genomics and Epigenomics ya Fudan University.Zomwe adachita pa kafukufukuyu zidasindikizidwa m'manyuzipepala apamwamba padziko lonse lapansi monga,Chilengedwe, Nature GeneticsndiJAMA.
idalembedwa m'manyuzipepala apamwamba apadziko lonse lapansi monga Nature, Nature Genetics ndi JAMA, zomwe zidakhudza kwambiri mfundo za 38.1.
CEO
Lin Hua
Bachelor of Economics ya Shanghai JiaoYunivesite ya Tong.Adakhala ngati Executive Manager wa Listed Company Department of Guosen Securities, mnzake wa XIANGDU CAPITAL, mnzake woyambitsa wa CHOBE CAPITAL.Monga mtsogoleri wa gulu, adalimbikitsa kuti akhazikitse makampani angapo ochita bwino.
ObiO(688238): CGT CDMO wopanga ndi mphamvu yaikulu;
Novoprotein (688137): wogulitsa zinthu zopangira zomwe zimayang'ana mapuloteni ophatikizananso;
Leadsynbio: kampani yotsogolera mu biology yopanga;
SinoBay: mabizinesi omwe akuwongolera chotupa
Quectel(603236): bizinesi yayikulu kwambiri padziko lonse lapansi yolumikizirana opanda zingwe
XinpelTek: yang'anani pamakampani opanda zingwe PA RF chip;
DGene: yang'anani kwambiri pabizinesi ya digito ya 3D
Kanema ++: bizinesi ya unicorn mdera la AI
Pazaka zopitilira khumi pamsika wamalikulu, Ms Hua adapeza luso lazambiri pakuwongolera makampani ndikuyika ndalama.
Mtsogoleri wa R&D
Wei Li, Ph.D.
Doctor Li wagwira ntchito ngati Associate Researcher mu Institute of Biological Science Fudan University kwa zaka khumi.Adatsogolera ntchito zofufuza zitatu kuphatikiza National Natural Science Foundation yaku China,Kafukufuku wodziyimira pawokha Pulojekiti yodziwitsa anthu malusondi ndi zina.Adachita nawo ntchito zingapo zadziko, kuphatikiza National 973 Project, Key Project of National Natural Science Foundation ndi zina zotero.Wasindikiza mapepala 16 a SCI monga wolemba woyamba kapena wolemba nawo muKafukufuku wa Genome, eBiomedicine, Nuclear Acid Research ndi etc.(Aggregate Impact Factor 158.97).
Zokonda pakufufuza:
1. Kupititsa patsogolo ma algorithms a epigenetic ndi maphunziro a multi-omics a chotupa pathogenesis.Gulu limodzi loyambira lidakhazikitsidwa koyambirira kwa genome-wide DNA methylation sequencing analysis platform (WGPS algorithm).Kenako mapu onse oyamba a DNA methylation a maselo a chiwindi apezeka.Pakadali pano, adapereka njira yatsopano yochepetsera jini ya chotupa pakuwona kwa epigenetics.
2. Onetsani zizindikiro zodziwika bwino zamakhalidwe oyipa amitundu ingapo ya khansa potengera ma multi-omics.Kutengera njira za WGPS, tidawunika zolembera zapadera za hypermethylation pakati pa zotupa ndi zabwinobwino.
3. Kafukufuku wa pathogenesis ya gene transcriptional activation ndi NamiRNA: Kalasi ya nyukiliya miRNA, yomwe tinaitcha NamiRNA (Nuclear Activating miRNA).
Medical R&D Engineer
Meigui Wang, Ph.D.
Dokotala Wang analandira Ph.D.digiri kuchokera ku South Medical University mu 2019. Anapitiliza maphunziro ake okhazikika mu Third Affiliated Hospital of Sun Yat-sen University(2019-2021).Chidwi chake chachipatala ndikuzindikira komanso kuchiza khansa yapamutu ndi khosi monga khansa yapakhosi komanso nasopharyngeal carcinoma.Zokonda zake zofufuza zimayang'ana pakuzindikira koyambirira kwa nasopharyngeal carcinoma.
Medical R&D Engineer
Yaping Dong, Ph.D.
Doctor Dong adalandira Ph.D.digiri mu zamankhwala azachipatala kuchokera ku Fujian Medical University mu 2020, ndipo adachita kafukufuku pambuyo pa udokotala ku Fudan University Shanghai Cancer Center kuyambira 2020 mpaka 2022. Monga wotenga nawo mbali wamkulu, adatenga nawo gawo pa National Projects zingapo, kuphatikiza Unduna wa Sayansi ndi Ukadaulo Key Program ya “ Kukula Kwatsopano Kwamankhwala Kwatsopano", National Natural Science Foundation yaku China ndi zina zotero.Wasindikiza mapepala angapo apamwamba kwambiri mu Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica ndi Radiation Oncology.